应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02126 药明巨诺-B
休市中 12-05 16:09:06
3.080
+0.050
+1.65%
最高
3.100
最低
2.950
成交量
95.45万
今开
3.010
昨收
3.030
日振幅
4.95%
总市值
12.81亿
流通市值
12.81亿
总股本
4.16亿
成交额
287.00万
换手率
0.23%
流通股本
4.16亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
“抗癌神药”屡登热搜,CAR-T如何从绝症救星走向百万患者?
21世纪经济报道 · 12-04 17:29
“抗癌神药”屡登热搜,CAR-T如何从绝症救星走向百万患者?
药明巨诺(开曼)(02126)11月股本维持不变
公告速递 · 12-03 18:00
药明巨诺(开曼)(02126)11月股本维持不变
药明巨诺-B12月01日遭主力抛售15.7万元
市场透视 · 12-01
药明巨诺-B12月01日遭主力抛售15.7万元
药明巨诺-B11月28日主力净流出16.4万元 散户资金买入
市场透视 · 11-28
药明巨诺-B11月28日主力净流出16.4万元 散户资金买入
CAR-T疗法破局红斑狼疮:国内这家药企临床试验实现中美双报双批
制药网 · 11-27
CAR-T疗法破局红斑狼疮:国内这家药企临床试验实现中美双报双批
药明巨诺-B盘中异动 早盘股价大涨5.30%报3.380港元
市场透视 · 11-27
药明巨诺-B盘中异动 早盘股价大涨5.30%报3.380港元
药明巨诺-B盘中异动 股价大涨5.25%
市场透视 · 11-24
药明巨诺-B盘中异动 股价大涨5.25%
药明巨诺-B11月18日遭主力抛售181.5万元
市场透视 · 11-18
药明巨诺-B11月18日遭主力抛售181.5万元
药明巨诺-B盘中异动 早盘大幅上涨5.10%
市场透视 · 11-13
药明巨诺-B盘中异动 早盘大幅上涨5.10%
药明巨诺-B11月07日主力净流出54.3万元 散户资金买入
市场透视 · 11-07
药明巨诺-B11月07日主力净流出54.3万元 散户资金买入
中新健康丨2025年国谈收官 “天价抗癌疗法”或迎支付破局
中国新闻网 · 11-05
中新健康丨2025年国谈收官 “天价抗癌疗法”或迎支付破局
药明巨诺-B11月05日主力净流出16.0万元 散户资金买入
市场透视 · 11-05
药明巨诺-B11月05日主力净流出16.0万元 散户资金买入
恒生医疗保健指数跌0.3% 医药股普遍走低 圣诺医药-B(02257)跌8.23%
金吾财讯 · 11-05
恒生医疗保健指数跌0.3% 医药股普遍走低 圣诺医药-B(02257)跌8.23%
药明巨诺-B盘中异动 早盘急速下跌5.45%
市场透视 · 11-04
药明巨诺-B盘中异动 早盘急速下跌5.45%
药明巨诺与再生元深化合作 获最高5000万美元里程碑付款
DoNews · 11-03
药明巨诺与再生元深化合作 获最高5000万美元里程碑付款
港股异动 | 药明巨诺-B涨超12%,报道称其CAR-T药物有望进入商保目录
智通财经 · 11-03
港股异动 | 药明巨诺-B涨超12%,报道称其CAR-T药物有望进入商保目录
Biotech和大药企全新合作方式,诞生
瞪羚社 · 11-03
Biotech和大药企全新合作方式,诞生
甘肃将牵头开展心脏瓣膜集采;五款CAR-T药物迎国谈博弈
21综合 · 11-03
甘肃将牵头开展心脏瓣膜集采;五款CAR-T药物迎国谈博弈
药明巨诺-B10月31日主力净流入68.8万元 散户资金抛售
市场透视 · 10-31
药明巨诺-B10月31日主力净流入68.8万元 散户资金抛售
药明巨诺-B10月30日主力净流出165.5万元 散户资金买入
市场透视 · 10-30
药明巨诺-B10月30日主力净流出165.5万元 散户资金买入
加载更多
公司概况
公司名称:
药明巨诺-B
所属市场:
SEHK
上市日期:
--
主营业务:
药明巨诺(开曼)有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。该公司建立了一个细胞免疫治疗产品开发的一体化平台以及一条涵盖血液恶性肿瘤、实体瘤及自身免疫性疾病的产品管线。该公司的主要产品倍诺达是该公司在Juno(一家百时美施贵宝的公司)的嵌合抗原受体T细胞(CAR-T)细胞工艺平台的基础上,自主开发的一款靶向CD19的自体CAR-T细胞免疫治疗产品。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02126","market":"HK","secType":"STK","nameCN":"药明巨诺-B","latestPrice":3.08,"timestamp":1764922146366,"preClose":3.03,"halted":0,"volume":954500,"delay":0,"floatShares":416000000,"shares":416000000,"eps":-1.5722286618501162,"marketStatus":"休市中","change":0.05,"latestTime":"12-05 16:09:06","open":3.01,"high":3.1,"low":2.95,"amount":2870005,"amplitude":0.049505,"askPrice":3.08,"askSize":25000,"bidPrice":3.06,"bidSize":6500,"shortable":0,"etf":0,"ttmEps":-1.6390458199554676,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1604332800000,"exchange":"SEHK","adjPreClose":3.03,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.1597615594261892,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02126","defaultTab":"news","newsList":[{"id":"2588887605","title":"“抗癌神药”屡登热搜,CAR-T如何从绝症救星走向百万患者?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588887605","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588887605?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:29","pubTimestamp":1764840543,"startTime":"0","endTime":"0","summary":"国内已上市的CAR-T疗法价格普遍在百万元左右。近期,价格高达百万的“抗癌针”屡屡登上热搜榜单。CAR-T细胞治疗产品凭借其独特的作用机制,能为患者带来可预见的治愈效果。经过多方咨询与考量,他们最终决定前往中国上海的曜影医院接受CAR-T治疗。上述分析师指出,全球CAR-T市场已形成“中美双强”的格局。2025年9月,中国科学技术大学团队针对系统性红斑狼疮的CAR-T疗法临床研究取得关键进展。连续四年,多款CAR-T产品冲刺国家医保目录均铩羽而归。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204173955952a98ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204173955952a98ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02171","02126","BK1583"],"gpt_icon":0},{"id":"1160093413","title":"药明巨诺(开曼)(02126)11月股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1160093413","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160093413?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:00","pubTimestamp":1764756046,"startTime":"0","endTime":"0","summary":"药明巨诺(开曼)于2025年12月3日发布截至2025年11月30日的股份变动月报表。根据公告,普通股本月底维持416,473,250股,较上月底并无新增发行或股份回购,注册股本维持在5,000,000,000股,对应注册股本总额50,000美元。公司披露其已采纳的首次公开发售前后激励计划继续有效,当月无任何期权行使或失效,潜在可发行或转让股份数量保持不变。报告同时显示,截至2025年11月30日,公司并未进行购回或注销活动。公司股本在本报告期内整体保持稳定,无任何增减变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02126"],"gpt_icon":0},{"id":"2588777425","title":"药明巨诺-B12月01日遭主力抛售15.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588777425","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588777425?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576934,"startTime":"0","endTime":"0","summary":"12月01日,药明巨诺-B股价收平报3.12元,成交金额186.9万元,换手率0.14%,振幅5.45%,量比0.88。药明巨诺-B今日主力资金净流出15.7万元,上一交易日主力净流出16.4万元。该股近5个交易日下跌3.42%,主力资金累计净流出32.1万元;近20日主力资金累计净流出226.2万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173595243ea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116173595243ea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02126","BK1161","BK1574"],"gpt_icon":0},{"id":"2587730523","title":"药明巨诺-B11月28日主力净流出16.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2587730523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587730523?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:15","pubTimestamp":1764317757,"startTime":"0","endTime":"0","summary":"11月28日, 药明巨诺-B股价跌2.80%,报收3.12元,成交金额185.3万元,换手率0.14%,振幅4.05%,量比0.71。药明巨诺-B今日主力资金净流出16.4万元,上一交易日主力净流出0万元。该股近5个交易日上涨2.62%,主力资金累计净流出16.4万元;近20日主力资金累计净流出303.8万元,其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128162421a4bff083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128162421a4bff083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","02126"],"gpt_icon":0},{"id":"2586213258","title":"CAR-T疗法破局红斑狼疮:国内这家药企临床试验实现中美双报双批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586213258","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586213258?lang=zh_cn&edition=full","pubTime":"2025-11-27 11:35","pubTimestamp":1764214523,"startTime":"0","endTime":"0","summary":"今年8月启函生物还宣布,其自主研发的通用型双靶点CAR-T细胞产品QT-019B新药临床试验申请已获得美国食品药品监督管理局正式批准。据悉,在CAR-T药物用于治疗系统性红斑狼疮等自免疾病的研发管线上,已有多家国内药企布局。CAR-T疗法以治疗血液肿瘤闻名,如今在自身免疫性疾病领域的突破,是其治疗潜力的又一次拓展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127113909a714489f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127113909a714489f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01093","02126","BK1583"],"gpt_icon":0},{"id":"2586400213","title":"药明巨诺-B盘中异动 早盘股价大涨5.30%报3.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586400213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586400213?lang=zh_cn&edition=full","pubTime":"2025-11-27 09:30","pubTimestamp":1764207002,"startTime":"0","endTime":"0","summary":"2025年11月27日早盘09时30分,药明巨诺-B股票出现异动,股价快速上涨5.30%。截至发稿,该股报3.380港元/股,成交量500股,换手率0.00%,振幅0.00%。资金方面,该股资金流入1690港元,流出0港元。药明巨诺-B股票所在的生物技术行业中,整体跌幅为0.24%。其相关个股中,派格生物医药-B、博安生物、腾盛博药-B涨幅较大,振幅较大的相关个股有荣昌生物、诺诚健华、康宁杰瑞制药-B,振幅分别为0.00%、0.00%、0.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093002951ca5e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251127093002951ca5e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2585493565","title":"药明巨诺-B盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585493565?lang=zh_cn&edition=full","pubTime":"2025-11-24 14:32","pubTimestamp":1763965928,"startTime":"0","endTime":"0","summary":"2025年11月24日下午盘14时32分,药明巨诺-B股票出现异动,股价快速拉升5.25%。截至发稿,该股报3.210港元/股,成交量61.85万股,换手率0.15%,振幅6.56%。资金方面,该股资金流入75.253万港元,流出103.076万港元。药明巨诺-B股票所在的生物技术行业中,整体涨幅为3.18%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511241432089516e30d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511241432089516e30d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2584996368","title":"药明巨诺-B11月18日遭主力抛售181.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584996368","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584996368?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:15","pubTimestamp":1763453736,"startTime":"0","endTime":"0","summary":"11月18日, 药明巨诺-B股价跌4.94%,报收3.27元,成交金额1072.1万元,换手率0.79%,振幅7.56%,量比2.94。药明巨诺-B今日主力资金净流出181.5万元,上一交易日主力净流出43.6万元。该股近5个交易日下跌4.61%,主力资金累计净流出185.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出399.5万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118161826a7015588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118161826a7015588&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1583","02126"],"gpt_icon":0},{"id":"2583354591","title":"药明巨诺-B盘中异动 早盘大幅上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583354591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583354591?lang=zh_cn&edition=full","pubTime":"2025-11-13 09:35","pubTimestamp":1762997701,"startTime":"0","endTime":"0","summary":"2025年11月13日早盘09时35分,药明巨诺-B股票出现波动,股价大幅拉升5.10%。截至发稿,该股报3.710港元/股,成交量11.05万股,换手率0.03%,振幅2.55%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为2.32%。其相关个股中,百济神州、来凯医药-B、药明巨诺-B涨幅较大,振幅较大的相关个股有映恩生物-B、来凯医药-B、歌礼制药-B,振幅分别为5.67%、4.36%、3.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113093501a49d9fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113093501a49d9fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","02126","BK1574","BK1161"],"gpt_icon":0},{"id":"2581833959","title":"药明巨诺-B11月07日主力净流出54.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581833959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581833959?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:15","pubTimestamp":1762503345,"startTime":"0","endTime":"0","summary":"11月07日, 药明巨诺-B股价跌4.99%,报收3.43元,成交金额724.7万元,换手率0.51%,振幅3.60%,量比0.57。药明巨诺-B今日主力资金净流出54.3万元,上一交易日主力净流入45.3万元。该股近5个交易日下跌0.57%,主力资金累计净流出106.8万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出764.6万元,其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107161948975a1813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107161948975a1813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02126","BK1574"],"gpt_icon":0},{"id":"2581739747","title":"中新健康丨2025年国谈收官 “天价抗癌疗法”或迎支付破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2581739747","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581739747?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:08","pubTimestamp":1762340901,"startTime":"0","endTime":"0","summary":"国家医保局8月公布了2025年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整形式审查的申报药品名单。“天价抗癌疗法”或迎来支付破局在今年的商保创新药目录中,天价“CAR-T疗法”无疑成为最大看点。截至目前,国内已有7款CAR-T疗法获批上市,定价普遍在百万元以上,此次有5款CAR-T疗法通过了商保目录的形式审查,其中3款同时申报了两个目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105190826a6e30a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105190826a6e30a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1191","BK1161","02171","06978","BK1515","02126","BK1593","BK1574"],"gpt_icon":0},{"id":"2581056694","title":"药明巨诺-B11月05日主力净流出16.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2581056694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581056694?lang=zh_cn&edition=full","pubTime":"2025-11-05 16:15","pubTimestamp":1762330549,"startTime":"0","endTime":"0","summary":"11月05日, 药明巨诺-B股价跌4.89%,报收3.50元,成交金额863.1万元,换手率0.59%,振幅4.89%,量比0.61。药明巨诺-B今日主力资金净流出16.0万元,上一交易日主力净流入11.4万元。该股近5个交易日下跌2.22%,主力资金累计净流出194.5万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出780.7万元,其中净流出天数为9日。该股主力净额占比0.01%,港股市场排名2416/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105162031a48a0852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105162031a48a0852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02126","BK1574","BK1583"],"gpt_icon":0},{"id":"2581061713","title":"恒生医疗保健指数跌0.3% 医药股普遍走低 圣诺医药-B(02257)跌8.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581061713","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581061713?lang=zh_cn&edition=full","pubTime":"2025-11-05 11:14","pubTimestamp":1762312498,"startTime":"0","endTime":"0","summary":"金吾财讯 | 恒生医疗保健指数日内跌0.3%,医药股普遍走低,圣诺医药-B(02257)跌8.23%,百奥赛图-B(02315)跌5.63%,荣昌生物(09995)跌4.73%,药明巨诺-B(02126)、科笛-B(02487)跌逾4%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969055","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","09995","09939","BK1161","LU2328871848.SGD","02126","BK1583","LU1969619763.USD","02487","BK1574","159506","BK1515","159938","02257"],"gpt_icon":0},{"id":"2580803274","title":"药明巨诺-B盘中异动 早盘急速下跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580803274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580803274?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:44","pubTimestamp":1762220666,"startTime":"0","endTime":"0","summary":"2025年11月04日早盘09时44分,药明巨诺-B股票出现异动,股价急速跳水5.45%。截至发稿,该股报3.820港元/股,成交量65.85万股,换手率0.16%,振幅8.91%。药明巨诺-B股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,维升药业-B、华康生物医学、帝王国际投资涨幅较大,振幅较大的相关个股有药明巨诺-B、科济药业-B、华康生物医学,振幅分别为8.42%、6.95%、6.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104094426a6df18d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104094426a6df18d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2580748472","title":"药明巨诺与再生元深化合作 获最高5000万美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2580748472","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580748472?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:58","pubTimestamp":1762160282,"startTime":"0","endTime":"0","summary":"药明巨诺近日宣布与再生元签署战略合作补充协议,进一步拓展双方合作关系。根据协议内容,药明巨诺将有望获得累计最高达5000万美元的款项,涵盖MAGE-A4产品开发、药品及慢病毒载体制造流程中的多项监管里程碑付款,并包括选择权行使费用。此次补充协议的达成,标志着双方在细胞治疗领域研发协作的持续深化,有助于加速关键项目的临床转化与产业化进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103170213a6dd7b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103170213a6dd7b65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02126","BK1583","BK1161"],"gpt_icon":0},{"id":"2580255291","title":"港股异动 | 药明巨诺-B涨超12%,报道称其CAR-T药物有望进入商保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2580255291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580255291?lang=zh_cn&edition=full","pubTime":"2025-11-03 09:59","pubTimestamp":1762135144,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,药明巨诺-B涨超10%,截至发稿,涨9.77%,报3.82港元,成交额463.31万港元。消息面上,据第一财经报道,11月2日,记者获悉,药明巨诺的CAR-T细胞药物瑞基奥仑赛注射液在谈判进入商保 创新药目录方面进展顺利,有望纳入该目录,降低患者用药负担,造福更多患者。这是国内获批上市的第一个国产1类CAR-T,上市后的定价是129万元/针。10月30日,药明巨诺宣布与再生元制药公司签署战略合作补充协议。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"628fecc566bce7ba17e7dea241a462ec","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364258.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02126","BK1583","BK4022","BK4230","BK1161"],"gpt_icon":0},{"id":"2580256323","title":"Biotech和大药企全新合作方式,诞生","url":"https://stock-news.laohu8.com/highlight/detail?id=2580256323","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580256323?lang=zh_cn&edition=full","pubTime":"2025-11-03 08:52","pubTimestamp":1762131145,"startTime":"0","endTime":"0","summary":"一种很新的Biotech和大药企之间的交易合作方式已经出现。尽管JWTCR001是引进的管线,但过往中国Biotech的交易历史来看,从未有过在同一个资产下引进方技术反哺授权方并获得技术授权付款的先河,药明巨诺和再生元这一创新式合作补充显然有很多价值挖掘点。01创新交易先河从国内Biotech过往合作交易历史上,与海外药企达成合作无非几种,包括买卖管线权益、技术平台使用授权、药物特许权折现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103085409a483ba71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103085409a483ba71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2580563362","title":"甘肃将牵头开展心脏瓣膜集采;五款CAR-T药物迎国谈博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2580563362","media":"21综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580563362?lang=zh_cn&edition=full","pubTime":"2025-11-03 07:59","pubTimestamp":1762127940,"startTime":"0","endTime":"0","summary":"政策动向甘肃将牵头开展心脏瓣膜集采10月31日,甘肃医保局发布《关于邀请参加心脏瓣膜类相关产品企业介绍会的通知》。此外,相关媒体报道显示,药明巨诺的CAR-T细胞药物瑞基奥仑赛注射液在谈判进入商保创新药目录方面进展顺利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110308052494eac49b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110308052494eac49b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02126","BK1574"],"gpt_icon":0},{"id":"2579458712","title":"药明巨诺-B10月31日主力净流入68.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2579458712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579458712?lang=zh_cn&edition=full","pubTime":"2025-10-31 16:15","pubTimestamp":1761898536,"startTime":"0","endTime":"0","summary":"10月31日, 药明巨诺-B股价涨0.87%,报收3.48元,成交金额1069.6万元,换手率0.75%,振幅5.80%,量比1.30。药明巨诺-B今日主力资金净流入68.8万元,上一交易日主力净流出165.5万元。该股近5个交易日下跌0.85%,主力资金累计净流出72.8万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出768.3万元,其中净流出天数为8日。该股主力净额占比0.05%,港股市场排名153/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161940974beb3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161940974beb3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02126"],"gpt_icon":0},{"id":"2579489068","title":"药明巨诺-B10月30日主力净流出165.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2579489068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579489068?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:15","pubTimestamp":1761812109,"startTime":"0","endTime":"0","summary":"10月30日, 药明巨诺-B股价跌4.17%,报收3.45元,成交金额1398.1万元,换手率0.98%,振幅7.50%,量比2.37。药明巨诺-B今日主力资金净流出165.5万元,上一交易日主力净流入37.4万元。该股近5个交易日下跌9.21%,主力资金累计净流出176.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出802.9万元,其中净流出天数为8日。该股主力净额占比0.12%,港股市场排名2631/2687。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030161529a47d5a74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030161529a47d5a74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1574","BK1583","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.12},{"period":"3month","weight":-0.4221},{"period":"6month","weight":0.6923},{"period":"1year","weight":1.3333},{"period":"ytd","weight":1.4063}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明巨诺(开曼)有限公司是一家主要从事细胞免疫治疗产品的研究及开发、生产及上市的公司。该公司建立了一个细胞免疫治疗产品开发的一体化平台以及一条涵盖血液恶性肿瘤、实体瘤及自身免疫性疾病的产品管线。该公司的主要产品倍诺达是该公司在Juno(一家百时美施贵宝的公司)的嵌合抗原受体T细胞(CAR-T)细胞工艺平台的基础上,自主开发的一款靶向CD19的自体CAR-T细胞免疫治疗产品。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.02582},{"month":2,"riseRate":0.8,"avgChangeRate":0.129974},{"month":3,"riseRate":0,"avgChangeRate":-0.16747},{"month":4,"riseRate":0.2,"avgChangeRate":-0.051907},{"month":5,"riseRate":0.6,"avgChangeRate":0.078145},{"month":6,"riseRate":0.4,"avgChangeRate":0.023117},{"month":7,"riseRate":0.4,"avgChangeRate":0.091377},{"month":8,"riseRate":0,"avgChangeRate":-0.160963},{"month":9,"riseRate":0.2,"avgChangeRate":-0.071154},{"month":10,"riseRate":0.2,"avgChangeRate":-0.118018},{"month":11,"riseRate":0.4,"avgChangeRate":0.158609},{"month":12,"riseRate":0.5,"avgChangeRate":-0.031365}],"exchange":"SEHK","name":"药明巨诺-B","nameEN":"JW THERAP-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明巨诺-B,02126,药明巨诺-B股票,药明巨诺-B股票老虎,药明巨诺-B股票老虎国际,药明巨诺-B行情,药明巨诺-B股票行情,药明巨诺-B股价,药明巨诺-B股市,药明巨诺-B股票价格,药明巨诺-B股票交易,药明巨诺-B股票购买,药明巨诺-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}